IMPROVEMENT IN NEUROMUSCULAR-TRANSMISSION IN MYASTHENIA-GRAVIS BY 3,4-DIAMINOPYRIDINE

被引：24
|
作者：
LUNDH, H
NILSSON, O
ROSEN, I
机构：
[1] UNIV LUND HOSP,DEPT CLIN NEUROPHYSIOL,S-22185 LUND,SWEDEN
[2] UNIV LUND HOSP,DEPT NEUROL,S-22185 LUND,SWEDEN
来源：
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE | 1985年 / 234卷 / 06期
关键词：
D O I：
10.1007/BF00386054
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：374 / 377
页数：4
相关论文
共 50 条
  • [21] PARKINSONS-DISEASE AND MYASTHENIA-GRAVIS - ADVERSE EFFECT OF TRIHEXYPHENIDYL ON NEUROMUSCULAR-TRANSMISSION
    UENO, S
    TAKAHASHI, M
    KAJIYAMA, K
    OKAHISA, N
    HAZAMA, T
    YORIFUJI, S
    TARUI, S
    NEUROLOGY, 1987, 37 (05) : 832 - 833
  • [22] NEUROMUSCULAR-TRANSMISSION IN NEONATAL MICE INJECTED WITH SERUM GLOBULIN OF MYASTHENIA-GRAVIS PATIENTS
    PAGALA, MKD
    TADA, S
    NAMBA, T
    GROB, D
    NEUROLOGY, 1982, 32 (01) : 12 - 17
  • [23] 3,4-DIAMINOPYRIDINE IN THE TREATMENT OF CONGENITAL (HEREDITARY) MYASTHENIA
    PALACE, J
    WILES, CM
    NEWSOMDAVIS, J
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1991, 54 (12): : 1069 - 1072
  • [24] Effect of 3,4-diaminopyridine at the murine neuromuscular junction
    Ng, Fiona
    Lee, Diana C.
    Schrumpf, Leah A.
    Mazurek, Mary E.
    Lee, Victoria
    Gill, Sharleen K.
    Maselli, Ricardo A.
    MUSCLE & NERVE, 2017, 55 (02) : 223 - 231
  • [25] Effects of 3,4-diaminopyridine on myasthenia gravis: Preliminary results of an open-label study
    Ceccanti, Marco
    Libonati, Laura
    Ruffolo, Gabriele
    Cifelli, Pierangelo
    Moret, Federica
    Frasca, Vittorio
    Palma, Eleonora
    Inghilleri, Maurizio
    Cambieri, Chiara
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [26] LEVAMISOLE TREATMENT DOES NOT AFFECT EMG-TESTED NEUROMUSCULAR-TRANSMISSION IN MYASTHENIA-GRAVIS
    PINELLI, P
    COSI, V
    PICCOLO, G
    IPPOLITI, G
    LOMBARDI, M
    SANDRINI, G
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1981, 377 (DEC) : 867 - 868
  • [27] THE EFFECTS OF CONTINUOUS VOLUNTARY ACTIVATION ON NEUROMUSCULAR-TRANSMISSION IN MYASTHENIA-GRAVIS AND MOTOR NEURON DISEASE
    DAVIS, GR
    SCHWARTZ, MS
    SWASH, M
    ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1983, 56 (03): : S64 - S64
  • [28] THE EFFECTS OF CORTICOSTEROID TREATMENT ON NEUROMUSCULAR-TRANSMISSION IN RATS WITH EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS (EAMG)
    WEIR, AI
    JOURNAL OF PHYSIOLOGY-LONDON, 1982, 329 (AUG): : P43 - P44
  • [29] CITRATE-INDUCED IMPAIRMENT OF NEUROMUSCULAR-TRANSMISSION IN HUMAN AND EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS
    WIRGUIN, I
    BRENNER, T
    SHINAR, E
    ARGOV, Z
    ANNALS OF NEUROLOGY, 1990, 27 (03) : 328 - 330
  • [30] A NEUROMUSCULAR-TRANSMISSION DISORDER - COMBINED MYASTHENIA-GRAVIS AND LAMBERT EATON SYNDROME IN ONE PATIENT
    TAPHOORN, MJB
    VANDUIJN, H
    WOLTERS, ECH
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1988, 51 (06): : 880 - 882
12345